Welcome to our dedicated page for Pavmed news (Ticker: PAVMZ), a resource for investors and traders seeking the latest updates and insights on Pavmed stock.
PAVmed Inc. reports developments for a diversified commercial-stage medical technology company operating across medical devices, diagnostics and digital health. News about PAVmed commonly covers business updates and financial results, Nasdaq listing compliance, convertible-debt and balance-sheet actions, and activity at subsidiaries such as Lucid Diagnostics and Veris Health.
Recurring updates include Lucid Diagnostics' commercial activity around the EsoGuard esophageal precancer test, insurance coverage and direct-contracting channels, and Veris Health's financing and development work for an implantable physiological monitor. PAVmed also discusses its incubator strategy, subsidiary financing, and capital-structure steps tied to its Nasdaq-listed common stock and Series Z warrants.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.